Filing Details
- Accession Number:
- 0001179110-20-001469
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-11 19:03:09
- Reporting Period:
- 2020-02-07
- Accepted Time:
- 2020-02-11 19:03:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235010 | Momenta Pharmaceuticals Inc | MNTA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1229450 | A Craig Wheeler | C/O Momenta Pharmaceuticals, Inc. 301 Binney Street Cambridge MA 02142 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-07 | 4,890 | $13.26 | 17,567 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-07 | 4,890 | $32.04 | 12,677 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-02-07 | 5,781 | $0.00 | 18,458 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-10 | 2,601 | $31.43 | 15,857 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restriced Stock Units | Acquisiton | 2020-02-07 | 100,000 | $0.00 | 100,000 | $0.00 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-02-07 | 200,000 | $0.00 | 200,000 | $31.87 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-02-07 | 2,423 | $0.00 | 2,423 | $13.26 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-02-07 | 2,467 | $0.00 | 2,467 | $13.26 |
| Common Stock | Restricted Stock Units | Disposition | 2020-02-07 | 5,781 | $0.00 | 5,781 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 100,000 | No | 4 | A | Direct | ||
| 200,000 | 2030-02-07 | No | 4 | A | Direct | |
| 4,124 | 2015-02-22 | 2021-02-22 | No | 4 | M | Direct |
| 57,653 | 2012-08-22 | 2021-02-22 | No | 4 | M | Direct |
| 23,126 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 36,725 | Indirect | Craig A Wheeler 2016 Annuity Trust |
| Common Stock | 48,263 | Indirect | Craig A Wheeler 2018 Annuity Trust |
| Common Stock | 419,934 | Indirect | Craig Wheeler Revocable Trust |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2018.
- This transaction was executed in multiple trades at prices ranging from $32.00 to $32.13. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017.
- Restricted Stock Units convert into common stock on a one-for-one basis.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 7, 2017.
- This transaction was executed in multiple trades at prices ranging from $30.91 to $31.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- Each Restricted Stock Unit represents a contingent right to receive one share of MNTA common stock.
- Represents restricted stock granted by the issuer pursuant to the issuer's 2013 Incentive Award Plan, as amended and restated.
- Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.
- Represents options granted by the issuer pursuant to the issuer's 2013 Incentive Award Plan, as amended and restated.
- Subject to certain criteria, the stock options will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.
Billionaire Hedge Funds
